By Cara Murez 

HealthDay Reporter

FRIDAY, March 31, 2023 (HealthDay Information) — Cats continually licking and chewing due to a pores and skin situation known as feline allergic dermatitis could profit from a brand new generic remedy authorised by the U.S. Meals and Drug Administration.

The FDA authorised Modulis for Cats on March 29, making it the primary generic cyclosporine oral resolution for cats with pores and skin situations ensuing from this allergic dermatitis.

The immunosuppressant drug tamps down the allergic course of that causes cats with this situation to be itchy.

The medicine accommodates the identical focus and dosage of cyclosporine as an authorised brand-name drug, Atopica for Cats. That medicine was authorised in August 2011.

Cats with this situation could be intensely itchy. They could lick, chew and scratch at their pores and skin and hair.

This could trigger them to develop different pores and skin points, together with miliary dermatitis, lesions referred to as eosinophilic plaques and hair loss.

Cats should be a minimum of 6 months outdated and weigh 3 kilos to make use of the medicine, which is barely accessible from a veterinarian.

Individuals who administer this to their cat ought to keep away from by chance ingesting the drug. Don’t eat, drink, smoke or use smokeless tobacco whereas dealing with it, the FDA suggested.

Wash your palms after giving Modulis for Cats to your pet. Folks with identified hypersensitivity to cyclosporine ought to keep away from contact with the product, the FDA warned.

The medicine is sponsored by Provetica, LLC, based mostly in Lenexa, Kan. It is available in three sizes.

Extra data

The American Affiliation of Feline Practitioners has extra on feline allergic dermatitis.

SOURCE: U.S. Meals and Drug Administration, information launch, March 29, 2023